Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Rhythm Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get RYTM alerts

About Jennifer Li

Jennifer Li is recorded as CFO at WeRide Inc. (WRD). Jennifer Li was last confirmed as Board Member at Flex Ltd. (FLEX) in a filing dated June 25, 2021. Jennifer Li has spoken on 6 earnings calls across 1 company, most recently for WeRide Inc. on November 20, 2026. WeRide Inc. is classified in the Software - Application industry within the Technology sector. Rhythm Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rhythm Pharmaceuticals, Inc. includes David P. Meeker, M.D. (CEO and Chairman), Hunter Smith (CEO and CFO), David Meeker (Chairman) and 6 others.

Jennifer Li on recent calls

“I will walk you through our financial and operating results for the third quarter of 2026. Let me start with three headlines. First, scale. Revenue grew 88% year-over-year to a record RMB 321.5 million, well ahead of straight expectations.”
CFO, Q3 FY2026 Earnings conference call (announced in 6-K) ·
“Let me start with the key message from the quarter. Q2 marks an important inflection point for V-Rite, with strong revenue growth, continued growth margin expansion, and increasing operating leverage across the businesses.”
CFO, WeRide Inc. 2026 Q2 & H1 Earnings Conference Call ·
“Before we dive into the financials, I want to highlight that all figures are in RMB. Comparisons are year-over-year, unless stated otherwise.”
CFO, WeRide Inc. Q1 FY2026 Earnings Call ·
“Before we dive into the financials, I want to highlight that all figures are in R&B, and comparisons are year-over-year, unless stated otherwise. Now, let's discuss our fourth quarter and full-year 2025 financial performance.”
CFO, WeRide Inc. Q4 FY2025 Earnings Call ·
“Before we get into the financials, please know that all amounts are in RMB and all comparisons are on a year-over-year basis, unless otherwise stated. Now let's discuss our first quarter financial performance.”
CFO, WeRide Inc. Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Electronic Components · Technology

Board Member

Since 2018-01-01, last confirmed 2021-06-25

Leadership on record at Rhythm Pharmaceuticals, Inc.

Recent activity